Ovarian cancer: epigenetics, drug resistance, and progression
Weiwei Xie(Nanfang Hospital), Xipeng Wang(Shanghai Jiao Tong University), Xiaoduan Li(Ministry of Natural Resources), Feikai Lin(Shanghai Jiao Tong University), Ziliang Wang(Jiangsu University), Huizhen Sun(National Center for Nanoscience and Technology)
Cited by 91
Related Papers
Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
|Frontiers in Immunology|2018|156
Ultrasound‐Amplified Enzyodynamic Tumor Therapy by Perovskite Nanoenzyme‐Enabled Cell Pyroptosis and Cascade Catalysis
|Advanced Materials|2022|154
Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells
|Theranostics|2020|146
Immunogenic Cell Death-Based Cancer Vaccines
|Frontiers in Immunology|2021|95